Citation Impact
Citing Papers
Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
2000
Thiazolidinediones
2004 Standout
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
Leptin and the control of obesity
2001
Exploring the characteristics of suboptimally controlled patients after 24 weeks of basal insulin treatment: An individualized approach to intensification
2016
Management of comorbidities in older patients with cystic fibrosis
2013
Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells
1998
Diabetic retinopathy
2010 Standout
Renoprotective effects of a novel inhibitor of advanced glycation
2001
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat
2001
Cystic fibrosis
2016 Standout
Chronic angiotensin (17) injection accelerates STZ-induced diabetic renal injury1
2008
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin
2004
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Cushing's syndrome
2015 Standout
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Retinal Vascular Lesions in Patients of Caucasian and Asian Origin With Type 2 Diabetes
2008
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Cyclic Cushing’s syndrome: a clinical challenge
2007
Role of Nitric Oxide in the Pathogenesis of Diabetic Nephropathy in Streptozotocin - Induced Diabetic Rats
1999
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
2016
Neuroendocrine correlates of chronic fatigue syndrome: A brief review
1997
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
Thyroid Hormone and the Cardiovascular System
2001 Standout
Prevalence of Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective
2012
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects
1994
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide
2014
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Acute Renal Failure
1996 Standout
Diabetic Retinopathy
2012 Standout
The Diagnosis of Cushing's Syndrome
2000
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes
2017
Biology of Incretins: GLP-1 and GIP
2007 Standout
Multimodal biomedical AI
2022 Standout
Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
2012
Prevalence of Diabetic Retinopathy in Urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I
2005
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Type 2 diabetes
2017 Standout
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients*
1995
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials
2015
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
2017 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Do sulphonylureas still have a place in clinical practice?
2018
Reduction in Triiodothyronine Levels Following Modified Fontan Procedure
1994
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Revised Equations for Estimated GFR From Serum Creatinine in Japan
2009 Standout
Cross-Sectional Study of Lipids and Liver Enzymes Related to a Serum Biomarker of Exposure (ammonium perfluorooctanoate or APFO) as Part of a General Health Survey in a Cohort of Occupationally Exposed Workers
2007
Degradation of Endogenous and Exogenous Gastric Inhibitory Polypeptide in Healthy and in Type 2 Diabetic Subjects as Revealed Using a New Assay for the Intact Peptide1
2000
The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme
2007
Comparison of dilated fundus examinations with seven-field stereo fundus photographs in the Veterans Affairs Diabetes Trial
2008
Adaptive designs in clinical trials: why use them, and how to run and report them
2018
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
2017
Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program
2017
Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic
2013
Microalbuminuria and Abnormal Ambulatory Blood Pressure in Adolescents With Type 2 Diabetes Mellitus
2005
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Cells in fluidic environments are sensitive to flow frequency
2005
A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms
2009
Hypothalamic-Pituitary-Adrenal Axis Reactivity in Chronic Fatigue Syndrome and Health Under Psychological, Physiological, and Pharmacological Stimulation
2002
Adipose Tissue as an Endocrine Organ
2004 Standout
Risk of radiocontrast nephropathy in patients with and without diabetes mellitus
1994
Acute hypothyroidism slows the rate of left ventricular diastolic relaxation
1989
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Cell Biology of the Glomerular Podocyte
2003 Standout
Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials
2015
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study
2016
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments
2015
Advanced Glycation End Products
2006 Standout
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
A meta‐analysis comparing clinical effects of short‐ or long‐acting GLP ‐1 receptor agonists versus insulin treatment from head‐to‐head studies in type 2 diabetic patients
2016
New insulins and newer insulin regimens: a review of their role in improving glycaemic control in patients with diabetes
2016
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Polyfluorinated Compounds: Past, Present, and Future
2011 Standout
The Early Natural History of Nephropathy in Type 1 Diabetes
2002
Oxidative Stress and Diabetic Complications
2010 Standout
How Reliable Is Estimation of Glomerular Filtration Rate at Diagnosis of Type 2 Diabetes?
2007
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
2019
Pharmacologic Therapy for Type 2 Diabetes Mellitus
1999
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice
2017
Diabetic Retinopathy and Diabetic Macular Edema
2003
The effect of addition of liraglutide to high‐dose intensive insulin therapy: a randomized prospective trial
2014
International Diabetes Federation 2017
2018 Standout
One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial
2015
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial ( BEGIN : ADD TO GLP ‐1 S tudy)
2016
Mechanisms of Diabetic Complications
2013 Standout
Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit
2016
Brain Corticosteroid Receptor Balance in Health and Disease*
1998 Standout
Impact of Obesity on Plasma Natriuretic Peptide Levels
2004
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
2019
Integrative physiology of human adipose tissue
2003
The Neuroendocrinology of Chronic Fatigue Syndrome
2003
Diabetic retinopathy management guidelines
2012
Higher Prevalence of Retinopathy in Diabetic Patients of South Asian Ethnicity Compared With White Europeans in the Community
2008
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta‐analysis
2016
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 Standout
Single-field fundus photography for diabetic retinopathy screening
2004
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
2010
Works of Jiten Vora being referenced
Mechanisms of glucose intolerance in cystic fibrosis
2009
Emerging role of insulin with incretin therapies for management of type 2 diabetes
2011
Simultaneous determination of glomerular filtration rate and effective renal plasma flow
1991
Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom
2013
Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus
1992
Prevalence of diabetic eye disease in patients entering a systematic primary care‐based eye screening programme
2002
A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations
2011
Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study
2003
Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study
1995
Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
2014
Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus
1998
Prevalence of diabetic eye disease in an inner city population: The liverpool diabetic eye study
1999
Incretin-based therapy in combination with basal insulin: A promising tactic for the treatment of type 2 diabetes
2012
Impact of initial treatment on renal function in newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus
1993
The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study
2013
Circadian and Ultradian Rhythm and Leptin Pulsatility in Adult GH Deficiency: Effects of GH Replacement
2001
Results from the UK cohort of SOLVE: Providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice
2014
Atrial natriuretic peptide in Type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function
1998
Hereditary pancreatic endocrine tumours
2004
Absorption of Radiolabeled Soluble Insulin in Type 1 (Insulin‐dependent) Diabetes: Influence of Subcutaneous Blood Flow and Anthropometry
1993
Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle‐aged men compared with those in young men
2003
Current concepts of renal hemodynamics in diabetes
1995
Non-mydriatic Polaroid photography in screening for diabetic retinopathy: evaluation in a clinical setting
1988
Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome.
1996
The safety and efficacy of adding once‐daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries
2012
Combining Incretin-Based Therapies With Insulin
2013
Enhanced renal sensitivity to angiotensin actions in diabetes mellitus in the rat
1996
The Circadian Rhythm of Osteoprotegerin and Its Association with Parathyroid Hormone Secretion
2007
Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.
1996
Interactions of the Kallikrein-Kinin and Renin-Angiotensin Systems in Experimental Diabetes
1997
Diabetic Renal Disease
1992
Relationship Between Absorption of Radiolabeled Soluble Insulin, Subcutaneous Blood Flow, and Anthropometry
1992
Cardiovascular events and all‐cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A B ayesian meta‐analysis of survival data
2016
Reversible Abnormalities of Myocardial Relaxation in Hypothyroidism
1985
Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24‐week, randomized, open‐label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart ( L anScape)
2015
Diagnostic difficulties in periodic Cushing's syndrome
1997
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
2015
Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir
2012
MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism?
2018